Futura Medical Announces AGM and Availability of Annual Report
The healthcare company announces its upcoming Annual General Meeting and the availability of its annual report.
The healthcare company announces its upcoming Annual General Meeting and the availability of its annual report.
The healthcare company has appointed a new broker to act as its sole broker and continue as Nominated Adviser.
The healthcare company reported its maiden profit and significant revenue growth, but warned of slower expansion and launch delays, impacting future performance expectations.
The healthcare company will announce its annual results and host investor presentations next month.
The healthcare company has appointed a new Non-executive Director with investment management experience.
The healthcare company reported strong FY24 results but drastically lowered FY25 expectations due to slower product adoption. A shift from anticipated profits to projected losses in FY25 has overshadowed the positive performance.
The healthcare company reports successful completion of a study for its women's sexual dysfunction treatment, paving the way for further development.
Pharmaceutical company Futura Medical announces routine update on Non-Executive Director remuneration.
Modest increase in stake by institutional investor in this healthcare company.
Biotechnology company Futura Medical sees minor shift in major shareholder position